Astellas, the biopharmaceutical company, has announced a significant expansion of its manufacturing site in Tralee, County Kerry. The move was reported on Monday, 14 September 2026, by the Irish Examiner and carried by several other outlets, including Radio Kerry, RTE.ie and the Irish Independent.
According to the Irish Independent, the expansion will double the plant's drug manufacturing capacity. The Irish Examiner describes the investment as a major expansion in Tralee, while RTE.ie reports it as further investment in the facility. IDA Ireland framed the announcement as a strengthening of Astellas' commitment to Ireland through the enlarged investment in the Tralee biopharmaceutical plant, according to idaireland.com.
The coverage did not include figures for the size of the investment, the number of jobs involved or a timeline for the work. Those details were not available in the material reviewed.
The announcement places the Tralee site at the centre of Astellas' Irish operations, with the company's presence in the region set to grow through the expanded facility. The reports focus on the scale of the capacity increase rather than on specific products or construction schedules.
What to watch next: whether Astellas or IDA Ireland releases the value of the investment, hiring plans and a completion date for the expanded Tralee plant.
